Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M

Journal of the Peripheral Nervous System

Volumn 12, Issue 2, 2007, Pages 102-107

  Benedetti, Luana ^a   Briani, Chiara ^b   Grandis, Marina ^a   Vigo, Tiziana ^a   Gobbi, Marco ^a   Ghiglione, Elisabetta ^a   Carpo, Marinella ^c   Cocito, Dario ^d   Caporale, Christina M ^e   Sormani, Maria P ^a   Mancardi, Giovanni L ^a   Nobile Orazio, Eduardo ^f   Schenone, Angelo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Anti MAG antibodies; Anti MAG polyneuropathy; IgM; Monoclonal gammopathy; Rituximab

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN M ANTIBODY; MYELIN; RITUXIMAB; STEROID;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOPENIA; MALE; PHYSICAL DISABILITY; POLYNEUROPATHY; PRIORITY JOURNAL; SENSORY NEUROPATHY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD19; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BLOTTING, WESTERN; ELECTROMYOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MYELIN-ASSOCIATED GLYCOPROTEIN; NEURAL CONDUCTION; POLYNEUROPATHIES;

EID: 34250186792     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2007.00129.x     Document Type: Article

References (13)

1. Broglio L, Lauria G (2005). Worsening after Rituximab treatment in anti-MAG neuropathy. Muscle Nerve 32 : 378 379.
2. Dalakas MC, Rakocevic G, Salajegheh K, Dambrosia J, Raju Raghavan, McElroy B (2006). A double-blind, placebo-controlled study of rituximab in patients with anti-MAG antibody-demyelinating polyneuropathy. Ann Neurol 60 : S91, S95.
3. Hughes R, Bensa S, Willison H, Van den Bergh P, Comi G, Illa I, Nobile-Orazio E, Van Doorn P, Dalakas M, Bojar M, Swan A the Inflammatory Neuropathy Cause and Treatment (INCAT) Group (2001). Randomized controlled trial of intravenous immunoglobulin versus oral prednilosone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50 : 195 201.
4. Kleyweg RP, van der Mechè FGA, Schmitz PIM (1991). Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barrè syndrome. Muscle Nerve 14 : 1103 1109.
5. Lunn MPT, Nobile-Orazio E (2003). Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev 1 : CD002827.
6. Maloney DG, Smith B, Rose A (2002). Rituximab: mechanism of action and resistance. Semin Oncol 29 : 2 9.
7. Merkies I, Schmitz P, Van Der Mechè F, Van Doorn P for the Inflammatory Neuropathy Cause and Treatment (INCAT) Group (2000). Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Neurology 54 : 943 949.
8. Monaco S, Bonetti B, Ferrari S, Moretto G, Nardelli E, Tedesco F, Mollnes TE, Nobile-Orazio E, Manfredini E, Bonazzi L, Rizzuto N (1990). Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N Engl J Med 322 : 649 652.
9. Nobile-Orazio E (1998). Neuropathies associated with anti-MAG antibodies and IgM monoclonal gammopathies. In : Immunological and Infectious Diseases of the Peripheral Nerve. Latov N, Wokke JHJ, Kelly JJ (Eds). Cambridge University Press, Cambridge, pp 169 189.
10. Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, Bonetti B, Cavaletti G, Gemignani F, Durelli L, Barbieri S, Allaria S, Sgarzi M, Scarlato G (1994). Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 36 : 416 424.
11. Pestronk A, Florence J, Miller T, Choski R, Miller T, Choksi R, Al-Lozi MT, Levine TD (2003). Treatment of IgM antibody associated polyneuropathies using rituximab. J Neurol Neurosurg Psychiatr 74 : 485 489.
12. Renaud S, Gregor M, Fuhr P, Lorenz D, Deuschl G, Gratwohl A, Steck AJ (2003). Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 27 : 611 615.
13. Renaud S, Fuhr P, Gregor M, Schweikert K, Lorenz D, Daniels C, Deuschl G, Gratwohl A, Steck AJ (2006). High-dose rituximab and anti-MAG-associated polyneuropathy. Neurology 66 : 742 744.